If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,174.00
Bid: 1,179.00
Ask: 1,184.00
Change: 20.00 (1.73%)
Spread: 5.00 (0.424%)
Open: 1,134.00
High: 1,188.00
Low: 1,134.00
Prev. Close: 1,154.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Directors

11 Jan 2018 07:00

RNS Number : 5311B
Fevertree Drinks PLC
11 January 2018
 

11th January 2018

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Appointment of Non-Executive Directors

Fever-Tree, the world's leading supplier of premium carbonated mixers, is pleased to announce the appointments of Kevin Havelock and Jeff Popkin as Non-Executive Directors of the Company with immediate effect.

 

Kevin Havelock (aged 60) has more than 25 years' drinks industry experience and is currently Global President, Refreshment at Unilever with responsibility for the Group's €10 billion revenue global beverages and ice cream business. Since joining Unilever in 1985, Kevin has held a wealth of senior leadership positions around the world, including Chairman for Unilever UK, Unilever France and Unilever Arabia as well as President, Unilever North America. He has been a member of the Unilever Executive Committee since 2011 and sits on the Group's Sustainability Board. Kevin also Co-Chairs the Pepsi/Lipton tea joint venture and became a Trustee of both the British Council and The Eden Project in 2017.

 

Jeff Popkin (aged 53) has significant experience across the North American beverage industry gathered over almost 30 years with particular expertise in sales and distribution in the US. His experience spans the beer, spirits, premium non-alcoholic carbonated soft drink and health & wellness beverage categories for a range of global brands. His leadership roles have included CEO of Red Bull Distribution, North America, President of Vita Coco and he is currently North American CEO of Mast-Jägermeister.

Bill Ronald, Chairman of Fever-Tree, comments; "On behalf of the Board, I am delighted to welcome Kevin and Jeff to Fever-Tree. They both have highly impressive track records across the beverage sector and a breadth of relevant international experience that will bring valuable insight and additional perspective to the Company."

 

"As well as being highly respected sector leaders, Kevin and Jeff are both huge admirers of Fever-Tree and I have no doubt they will make a significant contribution to the next stage of Fever-Tree's growth as we continue to pioneer the global mixer category."

 

For further information:

 

Fevertree Drinks plc

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Oliver Winters, Communications Director

+44 (0)20 7349 4922

FTI Consulting - Financial PR

Jonathon Brill

Georgina Goodhew

Fiona Walker

+44 (0)20 3727 1000

fever-tree@fticonsulting.com

Investec Bank plc - Nominated Adviser and Broker

Garry Levin

Alex Wright

David Anderson

+44 (0)20 7597 5970

 

 

 

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 60 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

 

Regulatory Disclosures

 

The following disclosures are required regarding Kevin John Havelock's appointment pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies:

 

Current directorships and partnerships:

The Eden Trust (Trustee)

British Council (Trustee)

Pepsi Lipton International Limited

Wm Morrison Supermarkets PLC (with effect from 1 February 2018)

 

Past directorships and partnerships held over the last 5 years:

None

 

Kevin has an indirect interest in 521 ordinary shares in the Company.

 

The following disclosures are required regarding Jeffrey Bradford Popkin's appointment pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies:

 

Current directorships and partnerships:

None

 

Past directorships and partnerships held over the last 5 years:

BrainGear Enterprises Inc.

 

Jeff has no direct or indirect interest in the Company's ordinary shares.

 

No further disclosure is required under AIM Rule 17 and paragraph (g) to Schedule Two of the AIM Rules for Companies with respect to Kevin Havelock or Jeff Popkin.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUCWGUPRGQU
Date   Source Headline
9th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSGrant of Options
1st May 20247:00 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSHolding(s) in Company
26th Mar 20247:00 amRNSFY23 Preliminary Results to 31 December 2023
25th Jan 202412:05 pmRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSFY23 pre-close trading update
18th Jan 20242:30 pmRNSAdmission Application
18th Jan 20242:30 pmRNSBlock Admission Application
14th Dec 20232:33 pmRNSDirectorate Change
1st Dec 20237:00 amRNSBlock Listing Return
1st Dec 20237:00 amRNSTotal Voting Rights
1st Nov 20238:55 amRNSTotal Voting Rights
26th Oct 20233:25 pmRNSDirector/PDMR Shareholding
28th Sep 20236:20 pmRNSHolding(s) in Company
14th Sep 202312:18 pmRNSDirector/PDMR Shareholding
12th Sep 20236:25 pmRNSFever-Tree FY23 Interim Results - Replacement
12th Sep 20237:00 amRNSFever-Tree FY23 Interim Results
1st Aug 20232:16 pmRNSTotal Voting Rights
3rd Jul 20234:00 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSBlock Listing Return
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20231:54 pmRNSResult of AGM
25th May 20237:00 amRNSBoard Changes
25th May 20237:00 amRNSAGM Trading Statement
12th May 202311:25 amRNSHolding(s) in Company
5th May 20237:00 amRNSGrant of Options
2nd May 20237:00 amRNSTotal Voting Rights
21st Apr 20231:08 pmRNSNotice of AGM
22nd Mar 20237:00 amRNSFY22 Preliminary Results to 31 December 2022
8th Mar 20239:49 amRNSHolding(s) in Company
8th Feb 20232:56 pmRNSStandard form for notification of major holdings
30th Jan 20234:32 pmRNSHolding(s) in Company
26th Jan 20237:00 amRNSFY22 pre-close trading update
17th Jan 20239:45 amRNSStandard form for notification of major holdings
19th Dec 20227:00 amRNSBlock Admission Application
12th Dec 20227:00 amRNSDomenic De Lorenzo to succeed Bill Ronald as Chair
1st Dec 20229:00 amRNSBlock Listing Return
21st Nov 20227:00 amRNSChange Of Nominated Advisor and Corporate Broker
15th Nov 20226:18 pmRNSStandard form for notification of major holdings
1st Nov 20227:00 amRNSTotal Voting Rights
17th Oct 20223:09 pmRNSStandard form for notification of major holdings
4th Oct 202210:25 amRNSDirector/PDMR Shareholding
3rd Oct 20229:00 amRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSFever-Tree FY22 Interim Results
1st Sep 20227:00 amRNSTotal Voting Rights
24th Aug 202212:06 pmRNSStandard form for notification of major holdings
19th Jul 20229:57 amRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSDirector/PDMR Shareholding
15th Jul 20224:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.